Detecting mutant KRAS in liquid biopsies: a biomarker searching for a role

Z Szallasi^{1

2}

Affiliations

Free article

Editorial

Z Szallasi. Ann Oncol. 2017.

Free article

. 2017 Apr 1;28(4):677-678.

doi: 10.1093/annonc/mdx056.

Z Szallasi^{1

2}

¹ Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston.
² Harvard Medical School, Boston, USA.

No abstract available

Comment on

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A, Alvarez H. Allenson K, et al. Ann Oncol. 2017 Apr 1;28(4):741-747. doi: 10.1093/annonc/mdx004. Ann Oncol. 2017. PMID: 28104621 Free PMC article.